# Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

> **NCT02756481** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 80 (actual)

## Conditions studied

- Non-Valvular Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02756481
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02756481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02756481, "Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02756481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*